About Marrow Access Technologies
Marrow Access Technologies is a private company based in Eden Prairie, Minnesota. It has reported $996,358 raised in four offerings on Form D since November 2018. Its chief executive is Joseph Saladino.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Apr 9, 2026 | $100,000of $300K target | 1 | $100K | Equity, DebtRule 506(b) | Form D ↗ |
| Mar 26, 2024 | Jun 17, 2024 | $241,358of $3.0M target | 2 | $120K | Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 21, 2023 | Jun 13, 2023 | $140,000of $2.0M target | 6 | $23,333 | Debt, OptionsRule 506(b) | Form D ↗ |
| Oct 30, 2018 | Nov 26, 2018amended Jun 26, 2020 | $515,000of $1.7M target | 18 | $28,611 | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $996,358 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Marrow Access Technologies's Form D filed Apr 9, 2026.